Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GZR102 vs GZR18 in type 2 diabetes with inadequate glycemic control on GLP-1 receptor agonists
NCT07055386Phase 2Active, not recruiting
- Sponsor
- Gan & Lee Pharmaceuticals
- Start
- Aug 2025
- Primary completion
- Jun 2026
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of GZR102 in type 2 diabetes mellitus (T2DM), sponsored by Gan & Lee Pharmaceuticals. Started Aug 2025; status: active, not recruiting.
02
Drugs
GZR102
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT07055386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07055386.